Skip to main content
Premium Trial:

Request an Annual Quote

DeltaDot Partners with Qatar in Proteomics Center

NEW YORK (GenomeWeb News) – DeltaDot will partner with the Qatar Science and Technology Park to open a proteomics research and testing services lab in Doha, the London-based company said on Monday.

Under the plan, QSTP will contribute $15 million to the partnership, while DeltaDot will provide staff, expertise, and it will grant QSTP an exclusive regional license to its technology.

Projects already in the works include biomarker studies for breast cancer and colorectal cancer and the metallic content of proteins, the company said.

The center will use DeltaDot's Label Free Intrinsic Imaging technology to develop new proteomics tools. The agreement also enables DeltaDot QSTP to market DeltaDot's products in the Middle East and North Africa region.

Eulian Roberts, who is managing director of QSTP, said in a statement that the agreement fits with Qatar's plans to become a center of scientific research by 2030.

DeltaDot CEO Paul James said in a statement that the venture will help the company develop its technology and applications and expand its life sciences offerings, and that the center will serve as "a core facility to attract new ventures to the region."

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.